Brief: Pharmaresearch Products Use Call Option In Promore Pharma

PMD Device Solutions AB

17/12/2018 17:13

Dec 17 (Reuters) - Promore Pharma AB  PROMO.ST :
    * PHARMARESEARCH PRODUCTS LTD USE CALL OPTION IN PROMORE PHARMA
    * COMPANY'S PARTNER AND THIRD LARGEST SHAREHOLDER PHARMARESEARCH PRODUCTS
LTD
(PRP) HAS CHOSEN TO EXERCISE CALL OPTION
    * CALL OPTION WAS GRANTED BY OTHER MAIN SHAREHOLDERS MIDROC NEW TECHNOLOGY
AB AND
ROSETTA CAPITAL IV SARL IN MAY 2017
    * TRANSACTION IS TAKING PLACE OUTSIDE STOCK MARKET
    * AFTER TRANSACTION MIDROC GROUP HOLDS 6.8 MILLION SHARES, ROSETTA 6.3
MILLION
SHARES AND PRP 4.8 MILLION SHARES IN PROMORE PHARMA

Source text for Eikon:  ID:nWkrf3Ctg 
Further company coverage:  PROMO.ST 

 ((Reuters.Briefs@thomsonreuters.com;))